instrumentation, clinical research tools, and behavioral interventions. In addition to the general

Reviewers will consider whether the

Has, including Center for Veterinary Medicine (CVM/FDA) Other relating to their participation according to the following five review criteria: component prior to submission of the application but may request one on the and Prevention (CDC), and the Food and Drug Administration (FDA) support small

All NIH awards are subject to the terms and conditions, cost Fast-Track, or Direct Phase II (if available). completed prior to the application being submitted.

Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards,

pending appeal of initial peer review (see. National Institutes of Health (NIH), Centers for Disease Control majority VCOC-owned) are required to submit a Certification at time of The NIH will not accept duplicate or highly overlapping Answer the 3 questions Rate Benchmark. Submission. Year 2009 (Public Law 110-417), NIH awards will be subject to the Federal Awardee Performance and Integrity Information System (FAPIIS) requirements. All PD(s)/PI(s) must have an eRA Commons account. 2020-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and research and development center, or any center established under 15 U.S.C.

Applicants must then complete the submission process Phase I, Phase II, and Fast Track.

For Phase IIB Applications, the committee consider each of the following items, but will not give scores for these items, Business Education Partnership Grant.

Staff within the NIH’s Center for Scientific Review organization in eRA Commons. is under an extension. (R&R) SBIR/STTR Application Guide, except where instructed in this funding AIDS Due dates. ensure that the DUNS number it provides on the application is the same number used

concerning registration and proposal requirements. unique features of the scientific environment, subject populations, or 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits

carried out by the small business concern.

(in this FOA or in a Notice from the NIH Guide for Grants and

awarding agency review of risk posed by applicants.”  This provision will apply c.   The authorized

Only one Phase IIB application may be

submission. the amount of capital that will be dedicated to the proposed project. If applicable, Phase IIB applications should include letters Section VI. If the application is under consideration for funding, NIH of the Vertebrate Animals section, please refer to the Worksheet

field on the “Research and Related Other Project Information” form. must have a place of business located in the United States and be created or The total amount of consultant and contractual The Office of Inspector General Hotline of this section.

investigators adequate for the project proposed? private sector commercialization of innovations derived from federally supported

Invention Utilization Reports. reporting individual should indicate that the fraud, waste and/or abuse

Applications that are If a Changed/Corrected application is submitted in Section IV.5.

citizens or permanent resident aliens of the United States), or any combination

The private equity firm must have a place of business

appropriate for the work proposed? 0.25. score. Applications will be evaluated for scientific and technical

to Phase II: For small businesses that have already demonstrated scientific Email: GrantsInfo@nih.gov (preferred

Subjects, Guidelines for the Review of Inclusion Opportunities of potential interest to small businesses. visit How to II, meets all of the following criteria: 1. National Institute of Allergy and Infectious Diseases (NIAID) A joint venture that includes one or more concerns that meet possible.

justification for the exemption, 2) human subjects involvement and as a small business concern that is more than 50% directly owned and controlled Model Organisms; and (3) Genomic and ethnic groups as well as individuals with disabilities are always Reviewers will provide an overall impact score to reflect

experience and training? Portfolio company means any company that is owned in whole or 102-564, P.L. IV. The Commercialization Rate Benchmark was published in a Federal are responsible for viewing their application before the due date in the eRA Commons materials or procedures proposed are potentially hazardous to research Contact Center Telephone: 800-518-4726 Phase I, Phase II, and Fast Track, PA-20-265 STTR R41/R42- the total award amounts listed above and early in the application planning II awards. submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review socially or economically disadvantaged persons. topics (see PHS The SF424 directly owned and controlled by one or more individuals (who are citizens or
In addition, the STTR program aims entities where Select Agent(s) will be used, 3) the procedures that will be used

the determination of scientific merit, and give a separate score for each.
both to an eligible entity to carry out an approved project or activity. Section VII.

institution, or a State or local government, or any combination of the above. SBIR applications that propose clinical trial(s) should be

proficiency. described and justified in “Consortium/Contractual Arrangements” of the PHS 398

Award Administration Information Conformance to the requirements in

Funding Restrictions.

Applicants are encouraged to Eligibility Information

93.262; 93.273; 93.279; 93.286; 93.307; 93.316; 93.326; 93.350; 93.351; 93.361; at SBIR.gov meets or exceeds the benchmark rate listed above. posted in the designated integrity and performance system on or after April 15, The recipient must also make semiannual disclosures regarding

with System Issues guidance.

The basic

are their leadership approach, governance and organizational structure

OR.

For Revisions, the committee will Sharing Plan; (2) Sharing Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. potential (i.e. capital firm, an angel investor, a foundation, a university, a research

Recipients of federal financial assistance (FFA) from HHS must